Reversible or irreversible phospho-Smad3 signaling between tumor-suppression and fibro-carcinogenesis in hepatitis B and C virus-related chronic liver diseases

被引：0
|
作者：
Yamaguchi, Takashi [1 ,2 ]
Yoshida, Katsunori [1 ,2 ]
Murata, Miki [1 ,2 ]
Tsuda, Rinako [1 ,2 ]
Tsuneyama, Koichi [3 ]
Matsuzaki, Koichi [1 ,2 ]
Seki, Toshihito [1 ,2 ]
Okazaki, Kazuichi [1 ,2 ]
机构：
[1] Kansai Med Univ, Dept Gastroenterol, Hirakata, Osaka, Japan
[2] Kansai Med Univ, Dept Hepatol, Hirakata, Osaka, Japan
[3] Univ Tokushima, Inst Hlth Biosci, Dept Mol & Environm Pathol, Tokushima, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
652
引用
收藏
页码：364 / 364
页数：1
相关论文
共 14 条
  • [1] REVERCIBLE PHOSPHORYLATED SMAD3 SIGNALING BETWEEN TUMOR-SUPPRESSION AND FIBRO-CARCINOGENESIS IN CHRONIC HEPATITIS C
    Matsuzaki, Koichi
    Inokuchi, Ryosuke
    Murata, Miki
    Yoshida, Katsunori
    Seki, Toshihito
    Okazaki, Kazuichi
    HEPATOLOGY, 2010, 52 (04) : 598A - 598A
  • [2] Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C
    Yamaguchi, Takashi
    Matsuzaki, Koichi
    Inokuchi, Ryosuke
    Kawamura, Rinako
    Yoshida, Katsunori
    Murata, Miki
    Fujisawa, Junichi
    Fukushima, Nobuyoshi
    Sata, Michio
    Kage, Masayoshi
    Nakashima, Osamu
    Tamori, Akihiro
    Kawada, Norifumi
    Tsuneyama, Koichi
    Dooley, Steven
    Seki, Toshihito
    Okazaki, Kazuichi
    HEPATOLOGY RESEARCH, 2013, 43 (12) : 1327 - 1342
  • [3] Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases
    Yamaguchi, Takashi
    Yoshida, Katsunori
    Murata, Miki
    Matsuzaki, Koichi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) : 12381 - 12390
  • [4] Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases
    Takashi Yamaguchi
    Katsunori Yoshida
    Miki Murata
    Koichi Matsuzaki
    World Journal of Gastroenterology, 2014, (35) : 12381 - 12390
  • [5] Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection
    Deng, Y. -R.
    Yoshida, K.
    Jin, Q. L.
    Murata, M.
    Yamaguchi, T.
    Tsuneyama, K.
    Moritoki, Y.
    Niu, J. Q.
    Matsuzaki, K.
    Lian, Z. -X.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (01): : 102 - 111
  • [6] TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases
    Koichi Matsuzaki
    Toshihito Seki
    Kazuichi Okazaki
    Journal of Gastroenterology, 2014, 49 : 971 - 981
  • [7] TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases
    Matsuzaki, Koichi
    Seki, Toshihito
    Okazaki, Kazuichi
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 971 - 981
  • [8] Reversible Human TGF- Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions
    Yoshida, Katsunori
    Murata, Miki
    Yamaguchi, Takashi
    Matsuzaki, Koichi
    Okazaki, Kazuichi
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (01):
  • [9] HBx shifts hepatic Smad3-mediated signaling from tumor-suppression to oncogenesis in chronic hepatitis B
    Murata, Miki
    Matsuzaki, Koichi
    Yoshida, Katsunori
    Sekimoto, Go
    Uemura, Yoshiko
    Sakaida, Noriko
    Fujisawa, Junichi
    Seki, Toshihito
    Koike, Kazuhiko
    Okazaki, Kazuichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A222 - A222
  • [10] SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection
    Vidalino, Laura
    Doria, Andrea
    Quarta, Santina M.
    Crescenzi, Marika
    Ruvoletto, Mariagrazia
    Frezzato, Federica
    Trentin, Livio
    Turato, Cristian
    Parolin, Maria Cristina
    Ghirardello, Anna
    Iaccarino, Luca
    Cavalletto, Luisa
    Chemello, Liliana
    Gatta, Angelo
    Pontisso, Patrizia
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 237 (07) : 793 - 802
12